![Romatoid artrit hastalarında Rituksimab (Mabthera) tedavisi ne zaman kullanılır? Bu tedaviyi alan hastalar nelere dikkat etmelidir? - Romatizma TV Romatoid artrit hastalarında Rituksimab (Mabthera) tedavisi ne zaman kullanılır? Bu tedaviyi alan hastalar nelere dikkat etmelidir? - Romatizma TV](https://romatizmatv.org/wp-content/uploads/2014/09/sytitle2-400x300.jpg)
Romatoid artrit hastalarında Rituksimab (Mabthera) tedavisi ne zaman kullanılır? Bu tedaviyi alan hastalar nelere dikkat etmelidir? - Romatizma TV
![Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase | British Journal of Cancer Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2013.371/MediaObjects/41416_2013_Article_BFbjc2013371_Fig1_HTML.jpg)
Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase | British Journal of Cancer
KISA ÜRÜN BĐLGĐSĐ 1. BEŞERĐ TIBBĐ ÜRÜNÜN ADI MABTHERA 500 mg/50 mL i.v. infüzyon için konsantre solüsyon içeren
![Roche's subcutaneous formulation of MabThera receives approval in Europe for people with chronic lymphocytic leukaemia » FINCHANNEL Roche's subcutaneous formulation of MabThera receives approval in Europe for people with chronic lymphocytic leukaemia » FINCHANNEL](https://finchannel.com/wp-content/uploads/2016/05/heallthandbeauty_mabthera.jpg)